
Non-radiographic axial spondyloarthritis (AXSPA) Program in Pharmaceutical Benefits Scheme (PBS) 012-18112216

-   Background
-   Process
-   Resources

[Expand/Collapse all sections]Expand all

For information on how to process a PBS Authority, see Processing
Written Authority Required Listings. Contact a Program Support Officer
(PSO) if unsure on how to action an application.

Non-radiographic axial spondyloarthritis quick reference

+-----------+-----------+-----------+-----------+-----------+-----------+
| Res       | Authority | PA        | P         | P         | P         |
| trictions | Level and | a         | rocessing | rescriber | rescriber |
|           | Section   | ssessment | System    | type      | s         |
|           |           |           |           |           | elf-serve |
+-----------+-----------+-----------+-----------+-----------+-----------+
| Initial   | Written   | Yes       | OPA       | Must be   |           |
|           |           |           |           | treated   |           |
| PB255     | S85:      |           |           | by a:     |           |
| form      |           |           |           |           |           |
|           | cer       |           |           | -   Rheum |           |
|           | tolizumab |           |           | atologist |           |
|           |           |           |           | -         |           |
|           | golimumab |           |           |  Clinical |           |
|           |           |           |           |     imm   |           |
|           | se        |           |           | unologist |           |
|           | cukinumab |           |           |           |           |
|           |           |           |           | No        |           |
+-----------+-----------+-----------+-----------+-----------+-----------+
| C         | Te        | No        | OPA       | Must be   |           |
| ontinuing | lephone/E |           |           | treated   |           |
|           | lectronic |           |           | by a:     |           |
|           |           |           |           |           |           |
|           | S85:      |           |           | -   Rheum |           |
|           |           |           |           | atologist |           |
|           | cer       |           |           | -         |           |
|           | tolizumab |           |           |  Clinical |           |
|           |           |           |           |     imm   |           |
|           | golimumab |           |           | unologist |           |
|           |           |           |           |           |           |
|           | se        |           |           | Yes       |           |
|           | cukinumab |           |           |           |           |
+-----------+-----------+-----------+-----------+-----------+-----------+
| Change or | Te        | No        | OPA       | Must be   |           |
| Recom     | lephone/E |           |           | treated   |           |
| mencement | lectronic |           |           | by a:     |           |
| after a   |           |           |           |           |           |
| break (<  | S85:      |           |           | -   Rheum |           |
| 5 years)  |           |           |           | atologist |           |
|           | cer       |           |           | -         |           |
|           | tolizumab |           |           |  Clinical |           |
|           |           |           |           |     imm   |           |
|           | golimumab |           |           | unologist |           |
|           |           |           |           |           |           |
|           | se        |           |           | Yes       |           |
|           | cukinumab |           |           |           |           |
|           |           |           |           |           |           |
|           |           |           |           |           |           |
+-----------+-----------+-----------+-----------+-----------+-----------+
| Recomme   | Te        | No        | OPA       | Must be   |           |
| ncement - | lephone/E |           |           | treated   |           |
| after a   | lectronic |           |           | by a:     |           |
| break (>  |           |           |           |           |           |
| 5 years)  | S85:      |           |           | -   Rheum |           |
|           |           |           |           | atologist |           |
|           | cer       |           |           | -         |           |
|           | tolizumab |           |           |  Clinical |           |
|           |           |           |           |     imm   |           |
|           | golimumab |           |           | unologist |           |
|           |           |           |           |           |           |
|           | se        |           |           | Yes       |           |
|           | cukinumab |           |           |           |           |
+-----------+-----------+-----------+-----------+-----------+-----------+
| Balance   | Te        | No        | OPA       | Must be   |           |
| of supply | lephone/E |           |           | treated   |           |
|           | lectronic |           |           | by a:     |           |
|           |           |           |           |           |           |
|           | S85:      |           |           | -   Rheum |           |
|           |           |           |           | atologist |           |
|           | cer       |           |           | -         |           |
|           | tolizumab |           |           |  Clinical |           |
|           |           |           |           |     imm   |           |
|           | golimumab |           |           | unologist |           |
|           |           |           |           |           |           |
|           | se        |           |           | Yes       |           |
|           | cukinumab |           |           |           |           |
+-----------+-----------+-----------+-----------+-----------+-----------+

                                   

-   Services Australia ABN 90 794 605 008 
